Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6803046 | BRACCO | Sincalide formulations |
Aug, 2022
(5 months ago) |
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10335502 | BRACCO | Freeze-dried formulation for gas-filled microvesicles |
Jul, 2038
(15 years from now) | |
US10232061 | BRACCO | Freeze-dried formulation for gas-filled microvesicles |
Jul, 2038
(15 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Patient Population (NPP) | Nov 13, 2022 |
Drugs and Companies using SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES ingredient
Market Authorisation Date: 15 October, 2014
Treatment: NA
Dosage: FOR SUSPENSION;INTRAVENOUS
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic